The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of duvelisib, a dual inhibitor of PI3K-δ,γ, on components of the tumor microenvironment in previously untreated follicular lymphoma.
 
Carla Casulo
Consulting or Advisory Role - Infinity Pharmaceuticals
Research Funding - Celgene (Inst)
 
Andre Goy
No Relationships to Disclose
 
Koen Van Eygen
No Relationships to Disclose
 
Juan-Manuel Sancho
No Relationships to Disclose
 
Mercadal Santiago
No Relationships to Disclose
 
Rod Johnson
No Relationships to Disclose
 
Kamal Bouabdallah
No Relationships to Disclose
 
Kam Sprott
Employment - Smerud Medical Research (I); Syros Pharmaceuticals (I); Verastem
Stock and Other Ownership Interests - Smerud Medical Research (I); Syros Pharmaceuticals (I); Verastem
Consulting or Advisory Role - Infinity Pharmaceuticals; X4 Pharma
Patents, Royalties, Other Intellectual Property - Syros Pharmaceuticals (I)
Travel, Accommodations, Expenses - Smerud Medical Research (I); Syros Pharmaceuticals (I); Verastem
 
Ngocdiep T. Le
Employment - Verastem
 
Jonathan A. Pachter
Employment - Verastem
 
David T. Weaver
Employment - Verastem